Skip to main content

Beneficial ownership — 13D / 13G

87,314 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
Broad Run Investment Management, LLC ECPG Encore Capital Group Inc 13G/A 4.8% 2y
HPS Investment Partners, LLC XPRO Expro Ltd 13G/A 4% 2y
Fourthstone LLC CHMG Chemung Financial Corp 13G 8.07% 2y
GLAZER CAPITAL, LLC AFAR Aura FAT Projects Acquisition Corp Class A Ordinary Shares 13G/A 14.35% 2y
RICE HALL JAMES & ASSOCIATES, LLC TRAK ReposiTrak, Inc. 13G/A 5.6% 2y
Shaolin Capital Management LLC GAQ Generation Asia I Acquisition Limited Class A Ordinary Shares 13G/A 2.99% 2y
GMB Culture Communication Co., Ltd. EPOW E-Power Inc. 13G 9.97% 2y
Lytton, Laurence W. XGN Exagen Inc. 13G/A 6.8% 2y
Beehouse, LLC AAWH Ascend Wellness Holdings, Inc. 13G/A 8.3% 2y
CVI Investments, Inc. GMDA Gamida Cell Ltd. Ordinary Shares 13G/A 4.9% 2y
MARSHALL WACE, LLP APGB Apollo Strategic Growth Capital II 13G/A 0% 2y
Kerry Propper FRXB Forest Road Acquisition Corp. II 13G/A 0% 2y
Theodore Walker Cheng-De King FEDU Four Seasons Education (Cayman) Inc. 13G/A 12.41% 2y
Sculptor Capital LP FLD Fold Holdings, Inc. 13G/A 0% 2y
M3 Funds, LLC MGYR Magyar Bancorp, Inc. 13G/A 8.74% 2y
PERCEPTIVE ADVISORS LLC ZYME Zymeworks Inc. 13G/A 1.5% 2y
PRICE T ROWE ASSOCIATES INC /MD/ MDB MongoDB, Inc. 13G/A 4.3% 2y
Shaolin Capital Management LLC BFAC Battery Future Acquisition Corp. 13G/A 5.09% 2y
CVI Investments, Inc. EOSE Eos Energy Enterprises, Inc. 13G/A 4.9% 2y
Kynam Capital Management, LP OLMA Olema Oncology, Inc. 13G/A 0% 2y
Radcliffe Capital Management, L.P. LOCC Live Oak Crestview Climate Acquisition Corp. 13G/A 0% 2y
FRONTIER CAPITAL MANAGEMENT CO.,LLC SRI Stoneridge Inc 13G/A 7.98% 2y
ORBIMED ADVISORS LLC NPCE NeuroPace Inc 13G/A 15.2% 2y
EcoR1 Capital, LLC RVMD Revolution Medicines, Inc. 13G/A 0.1% 2y
Oasis Management Co Ltd. CO Global Cord Blood Corporation 13G/A 9.91% 2y
Yiheng Capital Management, L.P. ACMR ACM Research, Inc. 13G/A 9.65% 2y
Venrock Healthcare Capital Partners III, L.P. ABVX Abivax S.A. 13G/A 5.7% 2y
TURTLE CREEK ASSET MANAGEMENT INC. JELD JELD-WEN Holding, Inc. 13G/A 16.4% 2y
First Trust Capital Management L.P. LCAA L Catterton Asia Acquisition Corp Class A Ordinary Shares 13G 8.77% 2y
EcoR1 Capital, LLC ZYME Zymeworks Inc. 13G/A 19.99% 2y
PRICE T ROWE ASSOCIATES INC /MD/ DAY Dayforce, Inc. 13G/A 12.4% 2y
Rosalind Advisors, Inc. NSPR InspireMD, Inc. 13G/A 9.9% 2y
ALLIANCEBERNSTEIN L.P. PNBK Patriot National Bancorp Inc 13G/A 9.8% 2y
Sculptor Capital LP DISA Disruptive Acquisition Corporation I Class A Ordinary Shares 13G/A 17.53% 2y
CADIAN CAPITAL MANAGEMENT, LP CRTO Criteo S.A. 13G 7.5% 2y
John A. Kryzanowski SYBX Synlogic, Inc. 13G/A 9.51% 2y
PRICE T ROWE ASSOCIATES INC /MD/ MOH Molina Healthcare, Inc. 13G 7.2% 2y
Clal Insurance Enterprises Holdings Ltd ALLT Allot Ltd. 13G/A 7.2% 2y
METEORA CAPITAL, LLC CSTAF Constellation Acquisition Corp I 13G 6.54% 2y
Walleye Capital LLC NIXX Nixxy, Inc. 13G 7.75% 2y
M3 Funds, LLC FNRN First Northern Community Bancorp 13G/A 5.69% 2y
Blue Ocean Sponsor LLC BOCN Blue Ocean Acquisition Corp Class A Ordinary Shares 13G/A 41.4% 2y
Indaba Capital Management, L.P. LAB Standard Biotools Inc. 13G/A 9.9% 2y
PERCEPTIVE ADVISORS LLC ACRV Acrivon Therapeutics, Inc. 13G/A 13.6% 2y
272 Capital LP HBIO Harvard Bioscience Inc 13G/A 6.9% 2y
GREAT POINT PARTNERS LLC AVTX Avalo Therapeutics, Inc. 13G/A 0.26% 2y
Weiss Multi-Strategy Advisers LLC SCOR Comscore, Inc. 13G/A 9.48% 2y
Caledonia (Private) Investments Pty Ltd LAWIL Light & Wonder, Inc. 13G/A 9.47% 2y
Altai Capital Management, L.P. DMRC Digimarc Corp 13G/A 14.1% 2y
M3 Funds, LLC BSBK Bogota Financial Corp. 13G/A 3.76% 2y